PRGO icon

Perrigo

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 38.1%
Negative

Positive
Benzinga
19 hours ago
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields
Neutral
PRNewsWire
6 days ago
Opill® Nails It with First-Ever Brand Collaboration, Launching 'Opill and Chill' With Chillhouse
Brands Will Donate One Pack of Opill® to NY Birth Control Access Project for Each Opill®-Themed Chill Tips Set Sold GRAND RAPIDS, Mich. , Oct. 9, 2025 /PRNewswire/ -- Today, Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced that Opill® — the first and only daily birth control pill available without a prescription in the U.S. —is partnering with self-care brand Chillhouse to launch 'Opill and Chill,' empowering women to make self-care a priority.
Opill® Nails It with First-Ever Brand Collaboration, Launching 'Opill and Chill' With Chillhouse
Positive
Seeking Alpha
19 days ago
51 September S&P Hi-Yield Aristocrats: 5 To Buy
The article highlights the top ten S&P Hi-Yield Aristocrats for September, with nine stocks offering attractive yields and fair pricing for dividend investors. Analyst forecasts project potential net gains of 21.59% to 66.98% by September 2026 for these high-yield 'dog' stocks, with average risk 31% below the market. Five lowest-priced Hi-Yield Aristocrats—AMCR, FLO, PRGO, BEN, RHI—are expected to outperform the higher-priced group, reflecting the classic 'Dogs of the Dow' strategy.
51 September S&P Hi-Yield Aristocrats: 5 To Buy
Neutral
PRNewsWire
1 month ago
Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference
DUBLIN , Aug. 20, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate in one-on-one investor meetings at the Barclays Global Consumer Staples Conference on Wednesday, September 3 rd, 2025. About Perrigo    Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe.
Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference
Positive
Zacks Investment Research
2 months ago
Are Investors Undervaluing Perrigo (PRGO) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Perrigo (PRGO) Right Now?
Negative
Zacks Investment Research
2 months ago
International Markets and Perrigo (PRGO): A Deep Dive for Investors
Review Perrigo's (PRGO) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
International Markets and Perrigo (PRGO): A Deep Dive for Investors
Negative
Zacks Investment Research
2 months ago
Perrigo (PRGO) Loses 16.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Perrigo (PRGO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Perrigo (PRGO) Loses 16.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Neutral
The Motley Fool
2 months ago
Perrigo (PRGO) Q2 EPS Rises 7.5%
Perrigo (PRGO) Q2 EPS Rises 7.5%
Perrigo (PRGO) Q2 EPS Rises 7.5%
Positive
Zacks Investment Research
2 months ago
Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut
PRGO tops Q2 EPS but misses revenue; trims 2025 sales outlook, sending shares down in pre-market.
Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut
Neutral
Seeking Alpha
2 months ago
Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript
Perrigo Company plc (NYSE:PRGO ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations & Corporate Communications Eduardo Guarita Bezerra - Executive VP & CFO Patrick Lockwood-Taylor - President, CEO & Director Conference Call Participants Ethan Harris Brown - JPMorgan Chase & Co, Research Division Keith Jude Devas - Jefferies LLC, Research Division Susan Kay Anderson - Canaccord Genuity Corp., Research Division Operator Good morning, ladies and gentlemen. Welcome to Perrigo Q2 2025 Financial Results Conference Call.
Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript